Amitriptyline hydrochloride and Pegasys drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Amitriptyline hydrochloride (amitriptyline hydrochloride) and Pegasys (peginterferon alfa 2a). Common drug interactions include fatigue among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Amitriptyline hydrochloride and Pegasys. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Amitriptyline hydrochloride?

Amitriptyline hydrochloride has active ingredients of amitriptyline hydrochloride. It is often used in migraine. eHealthMe is studying from 20,054 Amitriptyline hydrochloride users. Check the latest studies of Amitriptyline hydrochloride.

What is Pegasys?

Pegasys has active ingredients of peginterferon alfa 2a. It is often used in hepatitis c. eHealthMe is studying from 57,446 Pegasys users. Check the latest studies of Pegasys.



On Jul, 29, 2026

22 people who take Amitriptyline hydrochloride and Pegasys together, and have interactions are studied.

Amitriptyline hydrochloride and Pegasys drug interactions.

What are the common drug interactions of Amitriptyline Hydrochloride and Pegasys, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Platelet count decreased
  3. Anal abscess
  4. Bartholin's abscess (infection of one or both of the two bartholin's glands, which are located one on either side of the opening of the vagina)
  5. Drug ineffective
  6. Dysgeusia (disorder of the sense of taste)
  7. Nausea (feeling of having an urge to vomit)
  8. Pneumonia
  9. Psoriasis (immune-mediated disease that affects the skin)
  10. Anaemia (lack of blood)

male:

  1. Fatigue (feeling of tiredness)
  2. Decreased appetite
  3. Platelet count decreased
  4. Red blood cell count decreased
  5. White blood cell count decreased
  6. Balance disorder
  7. Full blood count decreased
  8. Haemoglobin increased
  9. Influenza like illness
  10. Pruritus (severe itching of the skin)

What are the common drug interactions of Amitriptyline Hydrochloride and Pegasys, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Agitation (state of anxiety or nervous excitement)
  2. Asthenia (weakness)
  3. Excitability
  4. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  5. Panic disorder
  6. Psychiatric symptom
  7. Restlessness (not able to rest)
  8. Somatisation disorder (a long-term (chronic) condition in which a person has physical symptoms that involve more than one part of the body)

30-39:

n/a

40-49:

  1. Anaemia (lack of blood)
  2. Platelet count decreased
  3. Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
  4. Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
  5. Osteopenia (a condition where bone mineral density is lower than normal)

50-59:

  1. Dysgeusia (disorder of the sense of taste)
  2. Fatigue (feeling of tiredness)
  3. Nausea (feeling of having an urge to vomit)
  4. Abdominal pain upper
  5. Arthralgia (joint pain)
  6. Decreased appetite
  7. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  8. Dyspnoea (difficult or laboured respiration)
  9. Flatulence (flatus expelled through the anus)
  10. Gastrointestinal pain

60+:

  1. Fatigue (feeling of tiredness)
  2. Decreased appetite
  3. Platelet count decreased
  4. Red blood cell count decreased
  5. White blood cell count decreased
  6. Balance disorder
  7. Drug ineffective
  8. Full blood count decreased
  9. Haemoglobin increased
  10. Influenza like illness

What are the existing conditions these people have? *

  1. Insomnia (sleeplessness): 5 people, 22.73%
  2. Depression: 5 people, 22.73%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 13.64%
  4. Stress And Anxiety: 2 people, 9.09%
  5. Nausea (feeling of having an urge to vomit): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Amitriptyline hydrochloride and Pegasys?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Amitriptyline hydrochloride and Pegasys:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Amitriptyline hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pegasys:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Amitriptyline hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pegasys and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on amitriptyline hydrochloride and peginterferon alfa 2a (the active ingredients of Amitriptyline hydrochloride and Pegasys, respectively), and Amitriptyline hydrochloride and Pegasys (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: